Clinical Trial Detail

NCT ID NCT01392209
Title Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

malignant glioma

astrocytoma

oligodendroglioma

mixed glioma

Therapies

Bevacizumab

Age Groups: adult

No variant requirements are available.